Calcium activates SK channels in the intact human lens

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 9, 2003, Pages 3927-3932

  Rhodes, Jeremy D ^a   Collison, David J ^b   Duncan, George ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHYL 2 BENZIMIDAZOLINONE; ADENOSINE TRIPHOSPHATE; APAMIN; BENZIMIDAZOLE DERIVATIVE; CALCIUM; CALCIUM IONOPHORE; EPIDERMAL GROWTH FACTOR RECEPTOR; FURA 2; GUANINE NUCLEOTIDE BINDING PROTEIN; IONOMYCIN; NEUROLEPTIC AGENT; POTASSIUM CHANNEL; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TRIFLUOPERAZINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALCIUM CELL LEVEL; CALCIUM ELECTRODE; CALCIUM SIGNALING; CATARACT; CHANNEL GATING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ELECTRIC POTENTIAL; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPOLARIZATION; IMAGING SYSTEM; LENS EPITHELIUM; MEMBRANE ELECTROPHYSIOLOGY; MYOTONIC DYSTROPHY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RISK FACTOR; SCHIZOPHRENIA;

AGED; AGED, 80 AND OVER; APAMIN; CALCIUM; CALCIUM CHANNEL AGONISTS; CALCIUM SIGNALING; ELECTROPHYSIOLOGY; FURA-2; GTP-BINDING PROTEINS; HUMANS; IONOMYCIN; LENS, CRYSTALLINE; MEMBRANE POTENTIALS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROTEIN-TYROSINE KINASES; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; TRIFLUOPERAZINE;

EID: 0042863132     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0013     Document Type: Article

References (42)

1. Duke-Elder S. Diseases of the lens and vitreous. In: Systems of Ophthalmology. Vol. 4. London: H Kimpton; 1969;183-188.
2. Junge J. Ocular changes in dystrophia myotonica. Ophthalmologica. 1968;155:291-293.
3. Abe T, Sato M, Kuboki J, Kano T, Tamai M. Lens epithelial changes and mutated gene expression in patients with myotonic dystrophy. Br J Ophthalmol. 1999;83:452-457.
4. Isaac NE, Walker AM, Jick H, Gorman M. Exposure to phenothiazine drugs and risk of cataract. Arch Ophthalmol. 1991;109:256-260.
5. McCarty CA, Wood CA, Fu CL, et al. Schizophrenia, psychotropic medication, and cataract. Ophthalmology. 1999;106:683-687.
6. Renaud JF, Desnuelle C, Schmid-Antomarchi H, Hugues M, Serratrice G, Lazdunski M. Expression of apamin receptors in muscle of patients with myotonic muscular dystrophy. Nature. 1986;319:678-680.
7. + channels in myotonic dystrophy. Muscle Nerve. 1994;17:1264-1270.
8. Chandy KG, Fantino E, Wittekindt O, et al. Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder. Mol Psychiatry. 1998;3:32-37.
9. Cardno AG, Bowen T, Guy CA, et al. CAG repeat length in the hKCa3 gene and symptom dimensions in schizophrenia. Biol Psychiatry. 1999;45:1592-1596.
10. Shepard AR, Rae JL. Ion transporters and receptors in cDNA libraries from lens and cornea epithelia. Curr Eye Res. 1998;17:708-719.
11. Parmelee JT, Beebe DC. Decreased membrane-permeability to potassium is responsible for the cell-volume increase that drives lens fibre cell elongation. J Cell Physiol. 1988;134:491-496.
12. Duncan G, Williams MR, Riach RA. Calcium cell signalling and cataract. Prog Retinal Eye Res. 1994;13:623-652.
13. Duncan G, Hightower KR, Gandolfi SA, Tomlinson J, Maraini G. Human lens membrane cation permeability increases with age. Invest Ophthalmol Vis Sci. 1989;30:1855-1859.
14. Duncan G, Patmore L, Pynsent PB. The impedance of the amphibian lens. J Physiol. 1981;312:17-27.
15. Rae JL, Thompson RD, Eisenberg RS. The effect of 2-4 dinitrophenol on cell to cell communication in the frog lens. Exp Eye Res. 1982;35:597-609.
16. Collison DJ, Duncan G. Regional differences in functional receptor distribution and calcium mobilization in the intact lens. Invest Ophthalmol Vis Sci. 2001;42:2355-2363.
17. Rhodes JD, Thomas GR, Duncan G. Acetylcholine-induced electrical responses in intact human, rat and rabbit lenses. Exp Eye Res. 2002;74:417-421.
18. Vergara C, Latorre R, Marrion NV, Adelman JP. Calcium-activated potassium channels. Curr Opin Neurobiol. 1998;8:321-329.
19. Kohler M, Hirschberg B, Bond CT, et al. Small-conductance, calcium-activated potassium channels from mammalian brain. Science. 1996;273:1709-1714.
20. Rimini R, Rimland JM, Terstappen GC. Quantitative expression analysis of the small conductance calcium-activated potassium channels, SK1, SK2 and SK3, in human brain. Mol Brain Res. 2000;85:218-220.
21. Liu CS, Wormstone IM, Duncan G, Marcantonio JM, Webb SF, Davies PD. A study of human lens cell growth in vitro: a model for posterior capsule opacification. Invest Ophthalmol Vis Sci. 1996;37:906-914.
22. Wormstone IM, Liu CS, Rakic JM, Marcantonio JM, Vrensen GF, Duncan G. Human lens epithelial cell proliferation in a protein-free medium. Invest Ophthalmol Vis Sci. 1997;38:396-404.
23. Thomas GR, Sanderson J, Duncan G. Thapsigargin inhibits a potassium conductance and stimulates calcium influx in the intact rat lens. J Physiol. 1999;516:191-199.
24. 2U receptors in human lens epithelial cells. J Physiol. 1995;486:273-282.
25. + channels. Am J Physiol. 2000;278:C570-C581.
26. Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev. 2000;52:557-593.
27. Wormstone IM, Tamiya S, Marcantonio JM, Reddan JR. Hepatocyte growth factor function and c-Met expression in human lens epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:4216-4222.
28. Xia X-M, Fakler B, Rivard A, et al. Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature. 1998;395:503-507.
29. Ca channel, IKCa1. J Biol Chem. 1999;274:5746-5754.
30. Thomas GR, Williams MR, Sanderson J, Duncan G. The human lens possesses acetylcholine receptors that are functional throughout life. Exp Eye Res. 1997;64:849-852.
31. Grunnet M, Jespersen T, Angelo K, et al. Pharmacological modulation of SK3 channels. Neuropharmacology. 2001;40:879-887.
32. Alvarez LJ, Candia OA, Zamudio AC. Acetylcholine modulation of the short-circuit current across the rabbit lens. Exp Eye Res. 1995;61:129-140.
33. Miller MJ, Rauer H, Tomita H, et al. Nuclear localization and dominant-negative suppression by a mutant SKCa3 N-terminal channel fragment identified in a patient with schizophrenia. J Biol Chem. 2001;276:27753-27756.
34. Ritsner M, Modai I, Ziv H, et al. An association of CAG repeats at the KCNN3 locus with symptom dimensions of schizophrenia. Biol Psychiatry. 2002;51:788-794.
35. Smith AA, Gavitt JA, Karmin M. Lenticular opacities induced in mice by chlorpromazine. Arch Ophthalmol. 1966;75:99-101.
36. Howard RO, McDonald CJ, Dunn CJ, Creasey WA. Experimental chlorpromazine cataracts. Invest Ophthalmol Vis Sci. 1969;8:413-421.
37. Wilson CC, Delamere NA, Paterson CA. Chlorpromazine effects upon rabbit lens water and electrolyte balance. Exp Eye Res. 1983;36:559-566.
38. Sanderson J, Gandolfi SA, Duncan G. Calmodulin antagonists induce changes in lens permeability and transparency. Curr Eye Res. 1994;13:219-224.
39. Terstappen GC, Pula G, Carignani C, Chen MX, Roncarati R. Pharmacological characterization of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines. Neuropharmacology. 2001;40:772-783.
40. + channels by cell volume changes. Pflugers Arch. 2002;444:167-177.
41. Roman R, Feranchak AP, Troetsch M, et al. Molecular characterization of volume-sensitive SKca channels in human liver cell lines. Am J Physiol. 2002;282:G116-G122.
42. Duncan G, Bushell AR. Ion analysis of human cataractous lenses. Exp Eye Res. 1975;20:223-230.